The Cell and Gene Therapy Catapult (CGT Catapult) is a British organisation focused on accelerating the development and commercialisation of cell and gene therapies. Established to bridge the gap between scientific research and industry, it supports the growth of the UK’s life sciences sector.

CGT Catapult collaborates with academics, businesses, and the government to create a thriving ecosystem for cell and gene therapy innovation. With a state-of-the-art manufacturing centre and specialist facilities, the organisation provides the expertise and infrastructure necessary for scaling up advanced therapies.

Key Products and Services

• Specialist consultancy in regulatory and clinical development
• Advanced therapy manufacturing services
• Training and upskilling for industry professionals
• Market access and commercialisation support
• R&D collaborations for therapy innovation

By enabling groundbreaking therapies to reach patients, CGT Catapult is cementing the UK’s position as a global leader in cell and gene therapy.